Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1325, 2002-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 8, 2011-12 ,pp. :
Access to resources
Recommend
By Jambart S Ammache Z Haddad F Younes A Hassoun A Abdalla K Selwan C Abou Sunna N Wajsbrot D Youseif E
The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. :
Pardoprunox monotherapy may provide benefit for patients with early-stage Parkinson's disease
Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. :
B-cell lymphoma vaccination may benefit certain patients with NHL
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
Zoledronic acid may provide a structural benefit in patients with early rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. :